--- title: 'Funding Daily Summary: What Happened on October 28, 2026' headline: Breast Cancer Now commits £800,000 to AI studies of breast cancer recurrence description: The funding backs two projects on why estrogen receptor-positive breast cancer can return years after treatment. url: https://thebench.bio/news/funding/2026-10-28 topic: funding date: '2026-10-28' covers: - '2026-10-28' date_published: '2026-10-28T12:02:12Z' date_modified: '2026-10-28T12:02:12Z' tags: - Software sources: 1 publisher: TheBench.Bio --- # Funding Daily Summary: What Happened on October 28, 2026 **Breast Cancer Now commits £800,000 to AI studies of breast cancer recurrence** The funding backs two projects on why estrogen receptor-positive breast cancer can return years after treatment. ## Today in brief Two research teams will share £800,000 from Breast Cancer Now to investigate late recurrence of estrogen receptor-positive breast cancer. [1] ## Two approaches to recurrence One team will use AI models and cancer-cell data to study how cancer cells become dormant, stay dormant and start growing again. [1] It will examine how dormant cancer cells interact with nearby immune cells, blood vessels and connective tissue for changes that might signal future recurrence. [1] A second team, led by Maggie Cheang, will analyze tumor samples from the POETIC trial using imaging, molecular methods and computational analysis. [1] The researchers will look for patterns linked to treatment resistance and later recurrence. [1] The researchers hope to identify risk indicators that might be detectable within two weeks of diagnosis and could eventually help tailor treatment and follow-up. [1] ## The day in numbers - **£800,000**: Funding committed to the two research projects. [1] - **Two weeks**: The researchers hope future risk indicators might be detectable within this time after diagnosis. [1] ## Sources 1. [Breast Cancer Now commits £800,000 to AI research into late breast cancer recurrence](), Pharmafile, 2026-10-28 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: